scholarly journals Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

The Lancet ◽  
2019 ◽  
Vol 393 (10174) ◽  
pp. 899-909 ◽  
Author(s):  
Caroline Ovadia ◽  
Paul T Seed ◽  
Alexandros Sklavounos ◽  
Victoria Geenes ◽  
Chiara Di Ilio ◽  
...  
2019 ◽  
Vol 90 (4) ◽  
pp. 217-222 ◽  
Author(s):  
Samettin Çelik ◽  
Canan S. Çalışkan ◽  
Handan Çelik ◽  
Mehmet Güçlü ◽  
Alper Başbuğ

2021 ◽  
Vol 16 (S3) ◽  
pp. 50-55
Author(s):  
Ana Maria SCUTELNICU ◽  
◽  
Brînduşa Ana CIMPOCA-RAPTIS ◽  
Anca Marina CIOBANU ◽  
Nicolae GICĂ ◽  
...  

Intrahepatic cholestasis of pregnancy is the most common liver disease during pregnancy. The main features are maternal pruritus, in the absence of a rash, and raised serum bile acids. Intrahepatic cholestasis of pregnancy is associated with an increased risk of adverse perinatal outcomes, including preterm birth, meconium-stained amniotic fluid, fetal asphyxia with neonatal unit admission or even stillbirth. The main treatment option is ursodeoxycholic acid. We review the etiology, diagnosis, adverse pregnancy outcomes, focusing especially on management of this intriguing condition.


Sign in / Sign up

Export Citation Format

Share Document